Thetis Pharmaceuticals LLC
Records under this name other than the patents Thetis Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Back to Thetis Pharmaceuticals LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,191,840 | Compositions and methods relating to salts of specialized pro-resolving mediators Lapsed on the fee record Ended Dec 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 7, 2025 | From the USPTO record |
| US 11,135,298 | Compositions and methods relating to salts of specialized pro-resolving mediators Lapsed on the fee record Ended Oct 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 5, 2025 | From the USPTO record |
| US 9,242,008 | Mineral amino-acid complexes of fatty acids Lapsed on the fee record Ended Jan 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 26, 2024 | From the USPTO record |
| US 10,399,552 | Method and device for operating a hydraulic brake system, brake system Lapsed on the fee record Ended Sep 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2023 | From the USPTO record |
| US 8,901,107 | Lipid-lowering antidiabetic agent Lapsed on the fee record Ended Dec 2, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 2, 2022 | From the USPTO record |
| US 8,765,811 | Tri-salt form of metformin Lapsed on the fee record Ended Jul 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2022 | From the USPTO record |
| US 9,999,626 | Mineral amino-acid complexes of active agents Lapsed on the fee record Ended Jun 19, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2022 | From the USPTO record |
| US 9,505,709 | Compositions and methods relating to ionic salts of peptides Lapsed on the fee record Ended Nov 29, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 29, 2020 | From the USPTO record |
| US 9,382,187 | Tri-salt form of metformin Lapsed on the fee record Ended Jul 5, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jul 5, 2020 | From the USPTO record |
| US 9,216,951 | Lipid-lowering antidiabetic agent Lapsed on the fee record Ended Dec 22, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 22, 2019 | From the USPTO record |